Stellar V Capital director passes; governance review planned

Q: When did SVCC learn of the director’s death?

The company became aware on November 6, 2025 .

Q: What board roles did Harry Brausnstein hold at SVCC?

He was chair of the Nominating and Corporate Governance Committee and a member of the Audit and Compensation Committees.

Q: Since when did the director serve on SVCC’s board?

He served since January 29, 2025 .

Q: What actions will SVCC’s board take next?

The Board will review committee composition and overall membership and take appropriate action per its governing documents.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Stellar V Capital Corp. (SVCC) reported a board change. On November 2, 2025, director Harry Brausnstein passed away; the company learned of his death on November 6, 2025. Mr. Brausnstein served as chair of the Nominating and Corporate Governance Committee and sat on the Audit and Compensation Committees since January 29, 2025.

The Board stated it will review its committee composition and overall membership in due course and take appropriate action under its amended and restated memorandum and articles of association.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Understanding 8-K Material Events →

11/07/2025 - 04:30 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

Current Report

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

November 2, 2025

Date of Report (Date of earliest event reported)

Stellar V Capital Corp.

(Exact Name of Registrant as Specified in its Charter)

Cayman Islands

001-42496

N/A

(State or other jurisdiction of
incorporation)

(Commission File Number)

(I.R.S. Employer
Identification No.)

230 Park Avenue, Suite 1540

New York, NY

10169

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s telephone number, including area code: (212) 661-7566

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Class A ordinary shares, par value $0.0001 per share	SVCC	The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share	SVCCW	The Nasdaq Stock Market LLC
Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant	SVCCU	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On November 2, 2025, Mr. Harry Brausnstein, a member of the board of directors (the “Board”) of Stellar V Capital Corp. (the “Company”), passed away. The Company became aware of Mr. Brausnstein’s death on November 6, 2025.

Mr. Brausnstein had served on the Company’s Board as the chair of the Nominating and Corporate Governance Committee and a member of the Audit Committee and the Compensation Committee since January 29, 2025. The Board will review the composition of its committees and overall membership in due course and will take appropriate action in accordance with the Company’s amended and restated memorandum and articles of association.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: November 7, 2025

	Stellar V Capital Corp.

	By:	/s/ Prokopios (Akis) Tsirigakis
	Name:	Prokopios (Akis) Tsirigakis
	Title:	Co-Chief Executive Officer

Source: View Original Filing on SEC EDGAR

FAQ

What did SVCC disclose in this 8-K?

SVCC disclosed that director Harry Brausnstein passed away on November 2, 2025.

When did SVCC learn of the director’s death?

The company became aware on November 6, 2025.

What board roles did Harry Brausnstein hold at SVCC?

He was chair of the Nominating and Corporate Governance Committee and a member of the Audit and Compensation Committees.

Since when did the director serve on SVCC’s board?

He served since January 29, 2025.

What actions will SVCC’s board take next?

The Board will review committee composition and overall membership and take appropriate action per its governing documents.

Does the filing change SVCC’s securities listing or symbols?

No. It lists SVCC (Class A shares), SVCCW (warrants), and SVCCU (units) on Nasdaq.